| 1 |
Caglayan AB, Beker MC, Sertel Evren E, Caglayan B, Kilic Ü, Ates N, Caglayan A, Dasdelen MF, Doeppner TR, Saarma M, Hermann DM, Kilic E. The Unconventional Growth Factors Cerebral Dopamine Neurotrophic Factor and Mesencephalic Astrocyte-Derived Neurotrophic Factor Promote Post-ischemic Neurological Recovery, Perilesional Brain Remodeling, and Lesion-Remote Axonal Plasticity. Transl Stroke Res 2023;14:263-77. [PMID: 35583716 DOI: 10.1007/s12975-022-01035-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Chen X, Zhang Y, Ding Q, He Y, Li H. Role of IL-17A in different stages of ischemic stroke. International Immunopharmacology 2023;117:109926. [DOI: 10.1016/j.intimp.2023.109926] [Reference Citation Analysis]
|
| 3 |
Feng S, Yang M, Liu S, He Y, Deng S, Gong Y. Oxidative stress as a bridge between age and stroke: A narrative review. Journal of Intensive Medicine 2023. [DOI: 10.1016/j.jointm.2023.02.002] [Reference Citation Analysis]
|
| 4 |
Phillips CM, Stamatovic SM, Keep RF, Andjelkovic AV. Epigenetics and stroke: role of DNA methylation and effect of aging on blood-brain barrier recovery. Fluids Barriers CNS 2023;20:14. [PMID: 36855111 DOI: 10.1186/s12987-023-00414-7] [Reference Citation Analysis]
|
| 5 |
Yu L, Wang J, Xia Y, Hou W, Yao X, Guo Y, Wang J, Wei H, Wang S. Adiponectin Promotes Neurogenesis After Transient Cerebral Ischemia Through STAT3 Mediated BDNF Upregulation in Astrocytes. Neurochem Res 2023;48:641-57. [PMID: 36315369 DOI: 10.1007/s11064-022-03790-y] [Reference Citation Analysis]
|
| 6 |
Neves LT, Paz LV, Wieck A, Mestriner RG, de Miranda Monteiro VAC, Xavier LL. Environmental Enrichment in Stroke Research: an Update. Transl Stroke Res 2023. [PMID: 36717476 DOI: 10.1007/s12975-023-01132-w] [Reference Citation Analysis]
|
| 7 |
Ercelen N, Karasu N, Kahyaoglu B, Cerezci O, Akduman RC, Ercelen D, Erturk G, Gulay G, Alpaydin N, Boyraz G, Monteleone B, Kural Z, Silek H, Temur S, Bingol CA. Clinical experience: Outcomes of mesenchymal stem cell transplantation in five stroke patients. Front Med (Lausanne) 2023;10:1051831. [PMID: 36744151 DOI: 10.3389/fmed.2023.1051831] [Reference Citation Analysis]
|
| 8 |
Phillips C, Stamatovic S, Keep R, Andjelkovic A. Epigenetics and stroke: role of DNA methylation and effect of aging on blood-brain barrier recovery. Res Sq 2023:rs. [PMID: 36711725 DOI: 10.21203/rs.3.rs-2444060/v1] [Reference Citation Analysis]
|
| 9 |
Eradath MK. Adult Neurogenesis: A Potential Target for Regenerative Medicine. Regenerative Medicine 2023. [DOI: 10.1007/978-981-19-6008-6_10] [Reference Citation Analysis]
|
| 10 |
Gao J, Yao M, Chang D, Liu J. mTOR (Mammalian Target of Rapamycin): Hitting the Bull's Eye for Enhancing Neurogenesis After Cerebral Ischemia? Stroke 2023;54:279-85. [PMID: 36321454 DOI: 10.1161/STROKEAHA.122.040376] [Reference Citation Analysis]
|
| 11 |
Wang Y, Zhong Y, Xu X, Li X, Li H, Shen H, Wang W, Fang Q. Axin1 participates in blood-brain barrier protection during experimental ischemic stroke via phosphorylation at Thr485 in rats. J Chem Neuroanat 2023;127:102204. [PMID: 36464067 DOI: 10.1016/j.jchemneu.2022.102204] [Reference Citation Analysis]
|
| 12 |
Yenkoyan K, Margaryan T, Matinyan S, Chavushyan V, Danielyan M, Davtyan T, Aghajanov M. Effects of β-amyloid (1-42) Administration on the Main Neurogenic Niches of the Adult Brain: Amyloid-Induced Neurodegeneration Influences Neurogenesis. Int J Mol Sci 2022;23. [PMID: 36499771 DOI: 10.3390/ijms232315444] [Reference Citation Analysis]
|
| 13 |
Zhou C, Zhou F, He Y, Liu Y, Cao Y. Exosomes in Cerebral Ischemia-Reperfusion Injury: Current Perspectives and Future Challenges. Brain Sci 2022;12. [PMID: 36552117 DOI: 10.3390/brainsci12121657] [Reference Citation Analysis]
|
| 14 |
Huang D, Qin J, Lu N, Fu Z, Zhang B, Tian S, Liu Q. Neuroprotective effects of nobiletin on cerebral ischemia/reperfusion injury rats by inhibiting Rho/ROCK signaling pathway. Ann Transl Med 2022;10:1385. [PMID: 36660614 DOI: 10.21037/atm-22-6119] [Reference Citation Analysis]
|
| 15 |
Zhang X, Yao W, Zhao W, Sun Y, Wu Z, He W, Ji Y, Gao Y, Niu X, Li L, Wang H. The construction of neurogenesis-related ceRNA network of ischemic stroke treated by oxymatrine. NeuroReport 2022;33:641-648. [DOI: 10.1097/wnr.0000000000001827] [Reference Citation Analysis]
|
| 16 |
Wang J, Ware K, Bedolla A, Allgire E, Turcato FC, Weed M, Sah R, Luo Y. Disruption of Sonic Hedgehog Signaling Accelerates Age-Related Neurogenesis Decline and Abolishes Stroke-Induced Neurogenesis and Leads to Increased Anxiety Behavior in Stroke Mice. Transl Stroke Res 2022;13:830-44. [PMID: 35146631 DOI: 10.1007/s12975-022-00994-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 17 |
Paro MR, Chakraborty AR, Angelo S, Nambiar S, Bulsara KR, Verma R. Molecular mediators of angiogenesis and neurogenesis after ischemic stroke. Rev Neurosci 2022. [PMID: 36073599 DOI: 10.1515/revneuro-2022-0049] [Reference Citation Analysis]
|
| 18 |
Liu Y, Yang G, Cui W, Zhang Y, Liang X. Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review. Front Pharmacol 2022;13:948600. [DOI: 10.3389/fphar.2022.948600] [Reference Citation Analysis]
|
| 19 |
Tang H, Li Y, Tang W, Zhu J, Parker GC, Zhang JH. Endogenous Neural Stem Cell-induced Neurogenesis after Ischemic Stroke: Processes for Brain Repair and Perspectives. Transl Stroke Res 2022. [PMID: 36057034 DOI: 10.1007/s12975-022-01078-5] [Reference Citation Analysis]
|
| 20 |
Aleksandrova MA, Sukhinich KK. Astrocytes of the Brain: Retinue Plays the King. Russ J Dev Biol 2022;53:252-271. [DOI: 10.1134/s1062360422040026] [Reference Citation Analysis]
|
| 21 |
Hong JY, Kim H, Yeo C, Jeon W, Lee J, Baek SH, Lee YJ, Ha I. Uwhangchungsimwon Inhibits Oxygen Glucose Deprivation/Re-Oxygenation-Induced Cell Death through Neuronal VEGF and IGF-1 Receptor Signaling and Synaptic Remodeling in Cortical Neurons. Antioxidants 2022;11:1388. [DOI: 10.3390/antiox11071388] [Reference Citation Analysis]
|
| 22 |
Asgari Taei A, Dargahi L, Khodabakhsh P, Kadivar M, Farahmandfar M. Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke. CNS Neurosci Ther 2022. [PMID: 35715988 DOI: 10.1111/cns.13886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Liu C, Zhang D, Lu Z, Man J, Zhang Z, Fu X, Cui K, Wang J. Metformin protects against pericyte apoptosis and promotes neurogenesis through suppressing JNK p38 MAPK signalling activation in ischemia/reperfusion injury. Neurosci Lett 2022;:136708. [PMID: 35660649 DOI: 10.1016/j.neulet.2022.136708] [Reference Citation Analysis]
|
| 24 |
Zheng T, Liu L, Li L, Gao Y, Guo R, Zhou Z, Liu Z, Liu K. Case Report: Advantages of High-Resolution MRI in Evaluating the Efficacy of Drug Therapy for Intracranial Atherosclerotic Plaques. Front Aging Neurosci 2022;14:804074. [DOI: 10.3389/fnagi.2022.804074] [Reference Citation Analysis]
|
| 25 |
Benedetti B, Couillard-despres S. Why Would the Brain Need Dormant Neuronal Precursors? Front Neurosci 2022;16:877167. [DOI: 10.3389/fnins.2022.877167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 26 |
Du H, Xu Y, Zhu L. Role of Semaphorins in Ischemic Stroke. Front Mol Neurosci 2022;15:848506. [DOI: 10.3389/fnmol.2022.848506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Onose G, Anghelescu A, Blendea D, Ciobanu V, Daia C, Firan FC, Oprea M, Spinu A, Popescu C, Ionescu A, Busnatu Ș, Munteanu C. Cellular and Molecular Targets for Non-Invasive, Non-Pharmacological Therapeutic/Rehabilitative Interventions in Acute Ischemic Stroke. Int J Mol Sci 2022;23:907. [PMID: 35055089 DOI: 10.3390/ijms23020907] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 28 |
Jurcau A, Simion A. Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies. Int J Mol Sci 2021;23:14. [PMID: 35008440 DOI: 10.3390/ijms23010014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 29 |
Romaus-sanjurjo D, Custodia A, Aramburu-núñez M, Posado-fernández A, Vázquez-vázquez L, Camino-castiñeiras J, Leira Y, Pías-peleteiro JM, Aldrey JM, Ouro A, Sobrino T. Symmetric and Asymmetric Synapses Driving Neurodegenerative Disorders. Symmetry 2021;13:2333. [DOI: 10.3390/sym13122333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Zheng X, Haupt M, Bähr M, Tatenhorst L, Doeppner TR. Treating Cerebral Ischemia: Novel Therapeutic Strategies from Experimental Stroke Research. Cerebral Ischemia 2021. [DOI: 10.36255/exonpublications.cerebralischemia.2021.therapy] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 31 |
Berlet R, Anthony S, Brooks B, Wang ZJ, Sadanandan N, Shear A, Cozene B, Gonzales-Portillo B, Parsons B, Salazar FE, Lezama Toledo AR, Monroy GR, Gonzales-Portillo JV, Borlongan CV. Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke. Biomolecules 2021;11:1316. [PMID: 34572529 DOI: 10.3390/biom11091316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 32 |
Ramos-Languren LE, Avila-Luna A, García-Díaz G, Rodríguez-Labrada R, Vázquez-Mojena Y, Parra-Cid C, Montes S, Bueno-Nava A, González-Piña R. Glutamate, Glutamine, GABA and Oxidative Products in the Pons Following Cortical Injury and Their Role in Motor Functional Recovery. Neurochem Res 2021. [PMID: 34387812 DOI: 10.1007/s11064-021-03417-8] [Reference Citation Analysis]
|
| 33 |
Amruta N, Engler-Chiurazzi EB, Murray-Brown IC, Gressett TE, Biose IJ, Chastain WH, Befeler JB, Bix G. In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice. Life Sci 2021;284:119881. [PMID: 34389403 DOI: 10.1016/j.lfs.2021.119881] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 34 |
Xiao F, Zhang X, Ni P, Yu H, Gao Q, Li M, Huo P, Wei Z, Wang S, Zhang Y, Zhao R, Li A, Li Z, Li Y, Cheng H, Du L, Ren S, Yu Q, Liu Y, Zhao Y. Voltage-dependent potassium channel Kv4.2 alleviates the ischemic stroke impairments through activating neurogenesis. Neurochem Int 2021;150:105155. [PMID: 34384853 DOI: 10.1016/j.neuint.2021.105155] [Reference Citation Analysis]
|
| 35 |
White TL, Gonsalves MA. Dignity neuroscience: universal rights are rooted in human brain science. Ann N Y Acad Sci 2021. [PMID: 34350987 DOI: 10.1111/nyas.14670] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 36 |
Vasan L, Park E, David LA, Fleming T, Schuurmans C. Direct Neuronal Reprogramming: Bridging the Gap Between Basic Science and Clinical Application. Front Cell Dev Biol 2021;9:681087. [PMID: 34291049 DOI: 10.3389/fcell.2021.681087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 37 |
Pan Y, Tian D, Wang H, Zhao Y, Zhang C, Wang S, Xie D, Zhang D, Zhu Y, Zhang Y. Inhibition of Perforin-Mediated Neurotoxicity Attenuates Neurological Deficits After Ischemic Stroke. Front Cell Neurosci 2021;15:664312. [PMID: 34262436 DOI: 10.3389/fncel.2021.664312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 38 |
Amruta N, Engler-chiurazzi EB, Murray-brown IC, Gressett TE, Biose IJ, Chastain WH, Bix G. In-vivo Protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice.. [DOI: 10.1101/2021.05.08.443275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Dordoe C, Chen K, Huang W, Chen J, Hu J, Wang X, Lin L. Roles of Fibroblast Growth Factors and Their Therapeutic Potential in Treatment of Ischemic Stroke. Front Pharmacol 2021;12:671131. [PMID: 33967812 DOI: 10.3389/fphar.2021.671131] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 40 |
Cuartero MI, García-Culebras A, Torres-López C, Medina V, Fraga E, Vázquez-Reyes S, Jareño-Flores T, García-Segura JM, Lizasoain I, Moro MÁ. Post-stroke Neurogenesis: Friend or Foe? Front Cell Dev Biol 2021;9:657846. [PMID: 33834025 DOI: 10.3389/fcell.2021.657846] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 41 |
Kang R, Gamdzyk M, Tang H, Luo Y, Lenahan C, Zhang JH. Delayed Recanalization-How Late Is Not Too Late? Transl Stroke Res 2021;12:382-93. [PMID: 33215347 DOI: 10.1007/s12975-020-00877-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 42 |
Gaire BP, Sapkota A, Choi JW. BMS-986020, a Specific LPA1 Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice. Antioxidants (Basel) 2020;9:E1097. [PMID: 33171697 DOI: 10.3390/antiox9111097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
